Karen Vousden
Vermögen: 1 Mio $ am 31.08.2026
Vermögen: 1 Mio $ am 31.08.2026
Dr. Karen H.
Vousden is an Independent Director at Bristol Myers Squibb Co., an Associate at National Academy of Sciences, a Council Member at European Molecular Biology Organization and a President at British Association for Cancer Research.
She is on the Board of Directors at Faeth Therapeutics, Inc. and Bristol Myers Squibb Co. Dr. Vousden was previously employed as a Co-Founder by Faeth Therapeutics LLC.
She also served on the board at The Beatson Institute For Cancer Research.
She received her doctorate degree from Queen Mary University of London.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.09.2026 | 42’631 ( 0.17% ) | 1 Mio $ | 31.08.2026 | |
| 12.03.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Direktor/Vorstandsmitglied | 01.01.2018 |
| FAETH THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 11.09.2026 |
European Molecular Biology Organization | Corporate Officer/Principal | - |
British Association for Cancer Research
British Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as a charity for cancer research | Präsident | - |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
The Beatson Institute For Cancer Research
The Beatson Institute For Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as cancer research institute | Direktor/Vorstandsmitglied | 01.01.2016 |
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
European Molecular Biology Organization | |
British Association for Cancer Research
British Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as a charity for cancer research | Commercial Services |
The Beatson Institute For Cancer Research
The Beatson Institute For Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as cancer research institute | Commercial Services |
Queen Mary University of London
Queen Mary University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells | Health Technology |
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen